TriSalus Life Sciences, Inc. (TLSI) on Tuesday said it has appointed Richard Marshall as chief medical officer, effective June 29, 2026.
Marshall will transition into the role from his current position as Medical Director, which he has held since January 2025.
He is an interventional radiologist with experience in interventional oncology, hepatobiliary interventions, and trauma care.
TriSalus Life Sciences shares closed at $3.98 on Monday, down 2.45%.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.